Advertisement
Advertisement

CMND

CMND logo

Clearmind Medicine Inc. Common Shares

1.63
USD
Sponsored
-0.12
-6.86%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

1.69

+0.06
+3.62%

Clearmind Medicine Inc. Common Shares Profile

About

Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Clearmind Medicine Inc. is based in VANCOUVER.

Info & Links

CEO

Adi Zuloff-Shani

Headquarters

101-1220 WEST 6TH AVENUE
VANCOUVER, A1 V6H1A5, CANADA

Industry

Medical Drugs

Sector

Medical

Website

www.clearmindmedicine.com

Auditor

Brightman Almagor Zohar & Co.

Share holders

--

Employees

--

Clearmind Medicine Inc. Common Shares Statistics

Valuation Measures

Market Capitalization2

2.51M

Enterprise Value

-8.82M

Enterprise Value/EBITDA(ttm)

1.09

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.16

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-143.79%

Return on Invested Capital(ttm)

-245.48%

Return on Assets(ttm)

-88.51%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-8.08M

Net Income Available to Common(ttm)

-7.90M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.75

52-Week Change

-99.60%

S&P 500 52-Week Change

21.41%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

96.05%

Balance Sheet

Total Cash(mrq)

13.59M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

85.60K

Total Debt/Equity(mrq)

0.74%

Current Ratio(mrq)

4.79%

Quick Ratio(mrq)

4.79%

Book Value Per Share(mrq)

11.28

Cash Flow

Operating Cash Flow Per Share(ytd)

-12.76

Free Cash Flow(ytd)

-3.85M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement